default author photo

Carolin Loos

Ragon Institute of MGH, MIT and Harvard

Boston, MA

United States

SCHOLARLY PAPERS

3

DOWNLOADS

86

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Collaboration between the Fab and Fc Contribute to Maximal Protection Against SARS-CoV-2 Following NVX-CoV2373 Subunit Vaccine with Matrix-M™ Vaccination

Number of pages: 41 Posted: 06 Apr 2021
Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology - Department of Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Texas Biomedical Research Institute, Texas Biomedical Research Institute, Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., University of Maryland - School of Medicine, University of Maryland - School of Medicine, University of Maryland - School of Medicine, Duke University - Duke Human Vaccine Institute, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla Institute for Allergy and Immunology (LIAI), Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc. and MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard
Downloads 31 (1,304,549)
Citation 1

Abstract:

Loading...

NVX-CoV2373 vaccine, Matrix-M™ adjuvant, SARS-CoV-2 spike glycoprotein, non-human primate, COVID-19

2.

Delayed Booster Dosing Modulates Human Antigen-Specific Ig and B Cell Responses to the RH5.1/AS01 B Malaria Vaccine

Number of pages: 55 Posted: 18 Feb 2022
University of Oxford, University of Oxford, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Harvard University - Ragon Institute of MGH, MIT and Harvard, University of Oxford, Harvard University - Ragon Institute of MGH, MIT and Harvard, University of Cambridge - Department of Engineering, University of Oxford, Ragon Institute of MGH, MIT and Harvard, National Institutes of Health (NIH) - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, University of Oxford, University of Freiburg - Institute of Experimental and Clinical Pharmacology and Toxicology, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, University of Sheffield, University of Oxford - The Jenner Institute, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard and University of Oxford
Downloads 29 (1,332,057)

Abstract:

Loading...

vaccines, dosing regimen, delayed booster, systems serology, B cell probes, single cell RNA sequencing, antibody, avidity, subclass, FcRn, B cells, plasma cells, malaria

3.

Delayed Booster Dosing Improves Human Antigen-Specific IG and B Cell Responses to the RH5.1/AS01 B Malaria Vaccine

Number of pages: 50 Posted: 09 Jun 2022
University of Oxford, University of Oxford, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Harvard University - Ragon Institute of MGH, MIT and Harvard, University of Oxford, Harvard University - Ragon Institute of MGH, MIT and Harvard, University of Cambridge - Department of Engineering, University of Oxford, Ragon Institute of MGH, MIT and Harvard, National Institutes of Health (NIH) - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, University of Oxford, University of Freiburg - Institute of Experimental and Clinical Pharmacology and Toxicology, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, University of Sheffield, University of Oxford - The Jenner Institute, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard and University of Oxford
Downloads 26 (1,372,601)

Abstract:

Loading...

B cells, vaccines, plasma cells, antibody, systems serology, single cell RNA sequencing, BCR repertoire, vaccine booster dosing, malaria, RH5